VTRNA2-1 and cancer: Together with the increased expression of nc886 in cancer, these data suggest another tumor surveillance model in which the increased nc886 during tumorigenesis activates OAS1 and induces apoptosis to eliminate pre-cancerous cells (Figure 3).